Research Paper Volume 14, Issue 24 pp 10050—10066

SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination

class="figure-viewer-img"

Figure 6. SGOL2 and RAB1A may regulate the microenvironment of prostate cancer. TCGA analysis displayed the relationship between SGOL2 (A), RAB1A (B) expression and immune cell enrichment.